利爾化學(002258.SZ):獨董馬毅親屬短線交易公司股票
格隆匯9月1日丨利爾化學(002258.SZ)公佈,公司收到獨立董事馬毅親屬馬楊明熙報吿,馬楊明熙存在6個月內買賣公司股票的行為。根據《證券法》、《深圳證券交易所上市公司規範運作指引》等相關法律法規的規定,其買賣行為構成短線交易。
經核查,馬楊明熙分別於2021年8月26日、8月31日、9月1日以競價交易方式合計買入公司股票2000股,於2021年8月30日以競價交易方式賣出公司股票1000股,其當前持有公司股票1000股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.